Computer program product for receiving a notification of a benefit after queuing the result of an evaluation of a sample for transmission

• US 20120284037A1
• Filed: 05/06/2011
• Published: 11/08/2012
• Est. Priority Date: 05/06/2011
• Status: Abandoned Application

• Current Assignee: Searete LLC (Intellectual Ventures LLC)
• Original Assignee: Searete LLC (Intellectual Ventures LLC)
• Inventors: Baym, Michael Hartmann, Hyde, Roderick A., Kare, Jordin T., Lieberman, Erez, Sweeney, Elizabeth A., Wood, Lowell L. Jr.
• Application Number:
  US13/068,298
• Publication Number:
  US 20120284037A1
• Time in Patent Office: Days
• US Class Current: 705/2
• CPC Class Codes: G16H 10/40 for data related to laboratory analysis, e.g. patient specimen analysis
• CPC Class Codes: G16H 40/67 for remote operation
• CPC Class Codes: G16H 50/20 for computer-aided diagnosis, e.g. based on medical expert systems
• CPC Class Codes: G16H 70/20 relating to practices or guidelines
• CPC Class Codes: Y02A 90/10 Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Abstract

A computer program product includes a recordable-type signal bearing medium bearing computer usable code configured for causing an automatic evaluation, remotely from a health care facility, of a biological sample acquired from a subject for a presence or an absence of at least one pathogen in the biological sample; computer usable code configured for electronically queuing a first result of the evaluation for transmission to an off-site entity; and computer usable code configured for receiving a notification of a benefit for the subject after queuing the first result of the evaluation for transmission.

Claims

1. A computer program product, comprising:

a recordable-type, non-transitory, signal-bearing medium bearing

computer usable code configured for causing an automatic evaluation, remotely from a health care facility, of a biological sample acquired from a subject for a presence or an absence of at least one pathogen in the biological sample;

computer usable code configured for electronically queuing a first result of the evaluation for transmission to an off-site entity; and

computer usable code configured for receiving a notification of a benefit for the subject after queuing the first result of the evaluation for transmission.

2. The computer program product of claim 1, wherein the biological sample comprises at least one of a fluid, cell, or tissue obtained via a nasal swab, an oral swab, a thoracic swab, a nasal aspirate, an oral aspirate, a thoracic aspirate, a nasal wash, an oral wash, a thoracic wash, a tissue scrape, phlegm, sputum, saliva, urine, or blood collected from the subject.

3. The computer program product of claim 1, wherein automatically evaluating, remotely from a health care facility, a biological sample acquired from a subject for a presence or an absence of at least one pathogen in the biological sample comprises:

evaluating the sample for a presence or an absence of at least one antigen or nucleic acid in the biological sample that is indicative of the presence or the absence of the at least one pathogen in the biological sample.

4. The computer program product of claim 1, wherein automatically evaluating, remotely from a health care facility, a biological sample acquired from a subject for a presence or an absence of at least one pathogen in the biological sample comprises:

evaluating the sample for a presence or an absence of at least one antibody immunoreactive with the at least one pathogen.

5. The computer program product of claim 4, wherein evaluating the sample for a presence or an absence of at least one antibody immunoreactive with the at least one pathogen comprises:

utilizing at least one of a lab-on-a-chip, an assay, a lateral flow test strip, a colorimetric test strip, a lateral flow colorimetric test strip, a transdermal testing device, or a lancet to determine the presence or the absence of the at least one antibody immunoreactive with the at least one pathogen.

6. The computer program product of claim 5, wherein the at least one of the lab-on-a-chip, the assay, the lateral flow test strip, the colorimetric test strip, the lateral flow colorimetric test strip, the transdermal testing device, or the lancet includes a unique identifier.

7. The computer program product of claim 6, wherein the unique identifier includes at least one of a bar code, an RFID tag, or a wireless tag.

8. The computer program product of claim 6, wherein the unique identifier further includes at least one of a lot number, a group assignment, a location of obtainment, a location of reporting, a date of obtainment, a date of reporting, a time elapsed between a date of obtainment and a date of reporting, or an evaluation module type.

9. The computer program product of claim 1, wherein the at least one pathogen includes at least one of a virus, a parasite, a bacterium, a fungus, a toxin, or a toxin-producing pathogen.

10. The computer program product of claim 1, wherein the at least one pathogen includes at least one of an influenza A virus, an influenza A virus subtype, an influenza B virus, or an influenza C virus.

11. The computer program product of claim 1, further comprising:

computer usable code configured for storing in an electronic memory information associated with the presence or the absence of the at least one pathogen in the biological sample.

12. The computer program product of claim 11, wherein the information associated with the presence or the absence of the at least one pathogen in the biological sample is stored in an encoded format.

13. The computer program product of claim 1, wherein the first result of the evaluation includes the presence or the absence of the at least one pathogen in the sample with respect to at least one of a value, a threshold, or a multiplicity of thresholds.

14. The computer program product of claim 1, wherein the first result of the evaluation includes a presence or an absence of at least one pathogenic antigen in the sample.

15. The computer program product of claim 1, wherein the first result of the evaluation includes a presence or an absence in the sample of at least one antibody immunoreactive with the at least one pathogen.

16. The computer program product of claim 1, further comprising:

computer usable code configured for reporting the presence or the absence of the at least one pathogen to the subject utilizing an obfuscation including at least one of an encoded format, an alphanumeric code, an image, or a spoken word format.

17. The computer program product of claim 16, wherein the subject initiates transmission of the obfuscated indication of the presence or the absence of the at least one pathogen to the off-site entity.

18. The computer program product of claim 1, further comprising:

computer usable code configured for automatically transmitting the first result of the evaluation to the off-site entity.

19. The computer program product of claim 1, further comprising:

computer usable code configured for transmitting the first result of the evaluation to the off-site entity.

20. The computer program product of claim 19, wherein transmitting the first result of the evaluation to the off-site entity comprises:

transmitting the first result of the evaluation to the off-site entity utilizing at least one of a wired connection, a wireless signal, a digital signal, a Radio Frequency Identification (RFID) tag signal, a communications network, or a wireless tag signal.

21. The computer program product of claim 19, wherein transmitting the first result of the evaluation to the off-site entity comprises:

transmitting the first result to an intermediate off-site entity for access by the off-site entity.

22. The computer program product of claim 19, wherein transmitting a first result of the evaluation occurs at a first time immediately subsequent to a second time the first result of the evaluation is electronically queued.

23. The computer program product of claim 19, wherein transmitting a first result of the evaluation occurs at a first time of reduced network activity subsequent to a second time the first result of the evaluation is electronically queued.

24. The computer program product of claim 19, wherein transmitting a first result of the evaluation occurs at a scheduled first time subsequent to a second time the first result of the evaluation is electronically queued.

25. The computer program product of claim 19, further comprising:

computer usable code configured for reporting a second result of the evaluation to the subject, wherein the second result of the evaluation is determined via the off-site entity.

26. The computer program product of claim 25, wherein the second result of the evaluation comprises the first result.

27. The computer program product of claim 25, wherein the second result of the evaluation comprises an alternate representation of the first result.

28. The computer program product of claim 19, further comprising:

computer usable code configured for conveying a notification of a benefit to the subject subsequent to transmitting the first result of the evaluation to the off-site entity.

29. The computer program product of claim 1, wherein the first result of the evaluation includes personal information regarding the subject.

30. The computer program product of claim 29, wherein the personal information regarding the subject includes at least one of a gender of the subject, a name of the subject, a generalization of a name, a biometric identification, a database pointer, a demographic, an alphanumeric referential identification, a numeric referential identification, an anonymization, an age of the subject, a family group of the subject, a location of the subject, or an ethnicity of the subject.

31. The computer program product of claim 29, wherein the personal information regarding the subject is provided by the subject.

32. The computer program product of claim 29, wherein the personal information regarding the subject is provided by a third party.

33. The computer program product of claim 29, wherein the personal information regarding the subject is determined via at least one of an HLA-type, a presence of a genetic marker, a sex hormone level, a Y-chromosomal test, a hormone level, a growth hormone level, or a blood group.

34. The computer program product of claim 29, wherein the personal information regarding the subject is provided via a lateral flow test strip, a colorimetric test strip, a lateral flow colorimetric test strip, a transdermal testing device, or a lancet.

35. The computer program product of claim 1, further comprising:

computer usable code configured for utilizing software configured to support the transmission of the first result of the evaluation to the off-site entity.

36. The computer program product of claim 35, wherein the software is configured to execute on at least one of the Internet, a personal communication device, a personal computer, a laptop computer, a palmtop computer, a Personal Digital Assistant (PDA), a mobile telephone, an image capture device, or a test strip.

37. The computer program product of claim 1, further comprising:

computer usable code configured for reporting a second result of the evaluation to the subject, wherein the second result of the evaluation comprises at least one of a diagnosis or a treatment regimen determined based on information associated with the presence or the absence of the at least one pathogen in the sample.

38. The computer program product of claim 1, further comprising:

computer usable code configured for reporting a second result of the evaluation to the subject, wherein the second result of the evaluation is determined via a reporting module.

39. The computer program product of claim 38, wherein the reporting module is associated with the reporting of the second result of the evaluation to the subject.

40. The computer program product of claim 1, wherein receiving a notification of a benefit for the subject comprises:

receiving the notification of the benefit for the subject via at least one of a wired connection, a wireless signal, a digital signal, a Radio Frequency Identification (RFID) tag signal, a communications network, or a wireless tag signal.

41. The computer program product of claim 1, wherein receiving a notification of a benefit for the subject comprises:

receiving the notification of the benefit directly or indirectly from the off-site entity.

42. The computer program product of claim 1, wherein the benefit is at least partially determined by the off-site entity.

43. The computer program product of claim 1, further comprising:

computer usable code configured for conveying a notification of a benefit for the subject.

44. The computer program product of claim 43, wherein conveying a notification of a benefit for the subject comprises:

conveying the notification of the benefit for the subject via at least one of a postal delivery, an e-mail, an alpha-numeric code, a printable document, a notification, a phone call, or a person-to-person contact.

45. The computer program product of claim 43, wherein the benefit is determined at least in part based upon the first result of the evaluation.

46. The computer program product of claim 43, wherein the benefit is determined at least in part based upon a location of the evaluation.

47. The computer program product of claim 43, wherein the benefit is determined at least in part based upon a time of the evaluation.

48. The computer program product of claim 43, wherein the benefit is determined at least in part based upon a time of the transmission of the first result.

49. The computer program product of claim 43, wherein the benefit is at least in part determined probabilistically.

50. The computer program product of claim 43, wherein the benefit includes a financial benefit.

51. The computer program product of claim 50, wherein the financial benefit includes at least one of a monetary benefit, a rebate, a discount, or a coupon.

52. The computer program product of claim 50, wherein the financial benefit includes a value less than a cost of evaluating the sample.

53. The computer program product of claim 50, wherein the financial benefit includes a value at least substantially equal to a cost of evaluating the sample.

54. The computer program product of claim 50, wherein the financial benefit includes a value greater than a cost of evaluating the sample.

55. The computer program product of claim 43, wherein the benefit is associated with providing a therapeutic benefit for the subject.

56. The computer program product of claim 55, wherein the therapeutic benefit includes at least one of a treatment for the subject, a qualification for treatment for the subject, or a priority status for treatment for the subject.

57. The computer program product of claim 43, wherein the benefit is associated with providing a preventative benefit.

58. The computer program product of claim 57, wherein the preventative benefit includes at least one of a vaccine, a qualification for a vaccine, or a priority status for a vaccine.

59. The computer program product of claim 57, wherein the preventative benefit includes a quarantine protocol.

60. The computer program product of claim 57, wherein the preventative benefit includes a notification of health personnel.

61. The computer program product of claim 43, wherein the benefit is associated with a diagnostic benefit.

62. The computer program product of claim 61, wherein the diagnostic benefit includes a recommendation for a test.

63. The computer program product of claim 61, wherein the diagnostic benefit includes a means for evaluating a second sample to determine a presence of at least one pathogen in the second sample.

64. The computer program product of claim 43, wherein the benefit includes a benefit for the subject.

65. The computer program product of claim 43, wherein the benefit includes a benefit for a person other than the subject.

66. The computer program product of claim 1, wherein the off-site entity comprises at least one of a medical care provider, a public health entity, or an insurance agency.

67. The computer program product of claim 1, wherein the off-site entity further comprises a receiving module for receiving the first result of the evaluation.

68. The computer program product of claim 1, wherein the off-site entity further comprises a database operably coupled to a receiving module for storing the first result of the evaluation.